ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Free access to stock market forums, expert advice, and real-time data to help you stay informed and grow your investments. ashapura logistics limited (ashalog) sees unusual trading volume - Free Top-Rated Stock Analysis ✌️【Part-Time Position】✌️ Receive professional stock analysis with real-time updates on market movements. Make quick investment decisions and capitalize on profitable opportunities.
ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Free access to stock market forums, expert advice, and real-time data to help you stay informed and grow your investments. The US Food and Drug Administration warned Thursday that it’s seized “thousands of units” of counterfeit versions of the type 2 diabetes drug Ozempic from the US drug supply chain, and it’s urging suppliers, pharmacies and patients to use caution. Five people have gotten sick in connection with the products, but none of the cases has been serious, theFDA said.
ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Expert guidance on stock market trends and real-time updates on stock indices, futures, and exchange rates. Make well-informed decisions and plan the best investment strategies for capital growth. The FDA warns pharmacies, health care systems, wholesalers and patients to double-check theirsemaglutideproducts to make sure they are the real thing. One-milligram injectable Ozempic products with the lot number NAR0074 and serial number 430834149057 on the box should not be used.
ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Real-time stock market data, precise predictions, and investment strategies to help you optimize your portfolio and achieve financial success. The agency and drugmaker Novo Nordisk are testing the fakes to determine whether they’re dangerous and to identify what the substance is. The pen label, carton, information for patients and health care professionals, and needles that come with the injectors are also counterfeit, the FDA said. The needles’ sterility can’t be confirmed, so using them could lead to infection.
ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Free expert predictions on stock trends and real-time data to help you make informed decisions and grow your wealth steadily. The FDA reminded patients to get their medication only through state-licensed pharmacies with a valid prescription.
Ozempic has been in shortage since a boom in popularity among celebrities who used it to lose weight. Since the popularity of Ozempic and its sister medication for weight loss, Wegovy, have grown, there have been reports of people selling knockoff versions at salons and through social media.
ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Accurate real-time market data and expert stock predictions for profitable investment opportunities in global markets. Separately, the FDA has also beensending lettersto online sellers warning them to stop selling knockoffs. Novo Nordisk has sued to keep medical spas, medical clinics and weight loss clinics from selling fake versions.
ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Expert stock predictions and free stock selection services to help you achieve optimal returns and long-term growth. The FDA said it is working with other federal agencies and Novo Nordisk to remove additional counterfeit semaglutide injectable products.
Consumers can call Novo Nordisk at 1-800-727-6500 if they have questions or find fake products. People can also report the counterfeit products to their localFDA consumer complaint coordinatoror on theFDA’s website.
Correction: This story has been updated to properly reflect the amount of counterfeit Ozempic seized.
ashapura logistics limited (ashalog) sees unusual trading volume ✌️【Part-Time Position】✌️ Get precise stock market predictions and free access to real-time market data for efficient decision-making and portfolio growth.